SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020818
Filing Date
2021-08-20
Accepted
2021-08-20 16:31:31
Documents
74
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1534842
2 ex31-1.htm EX-31.1 19446
3 ex31-2.htm EX-31.2 19652
4 ex32-1.htm EX-32.1 6141
5 ex32-2.htm EX-32.2 6459
  Complete submission text file 0001493152-21-020818.txt   8437756

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT otlc-20210630.xsd EX-101.SCH 59181
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT otlc-20210630_cal.xml EX-101.CAL 59204
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT otlc-20210630_def.xml EX-101.DEF 354431
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT otlc-20210630_lab.xml EX-101.LAB 478580
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT otlc-20210630_pre.xml EX-101.PRE 449415
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1316941
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 211194250
SIC: 2834 Pharmaceutical Preparations